05:06 PM EST, 11/14/2025 (MT Newswires) -- Repare Therapeutics ( RPTX ) said Friday it has signed a definitive arrangement agreement with XenoTherapeutics and Xeno Acquisition Corp. under which Xeno will buy all of Repare common shares.

Repare said it expects each Repare shareholder to get a cash payment of $1.82 per common share at closing, and in addition, each Repare shareholder will also get one non-transferable contingent value right for each share that entitles the holder to receive some cash payments.

After completion of the deal, Repare will become a privately held company, and its shares will be delisted from Nasdaq, it said, adding the deal is expected to close in Q1 2026.

Repare shares were halted in recent after-hours activity.